Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites

Table 1 Comparison of clinical data between the two groups

Group		Survival group (n = 45 cases)	Deceased group (n = 30 cases)	t/χ2	P value
Age (yr)		51.42 ± 7.28	53.25 ± 7.09	1.078	0.285
Sex	Male	26	16	0.144	0.704
	Female	19	14
Combined background disease	Presence	15	12	0.347	0.556
	Absence	30	18
Family history	Presence	4	5	1.031	0.310
	Absence	41	25
Smoking history	Presence	12	11	0.847	0.358
	Absence	33	19
Drinking history	Presence	10	10	1.136	0.286
	Absence	35	20
AST (U/L)		54.29 ± 11.57	60.72 ± 14.09	2.160	0.034
ALT (U/L)		40.31 ± 9.86	45.19 ± 10.52	2.044	0.045
ALP (U/L)		121.90 ± 30.37	129.74 ± 32.37	1.067	0.290
GGT (U/L)		64.86 ± 16.25	70.38 ± 18.39	1.367	0.176
Tbil (μmol/L)		44.93 ± 13.64	54.07 ± 16.76	2.593	0.012
Alb (g/L)		29.52 ± 8.53	24.67 ± 7.91	2.482	0.015
Scr (μmol/L)		66.04 ± 10.38	72.21 ± 12.86	2.290	0.025
BUN (μmol/L)		7.23 ± 2.07	7.41 ± 2.18	0.361	0.719
Na+ (mmol/L)		136.24 ± 18.67	126.74 ± 12.35	2.450	0.017
PLT (× 109/L)		60.03 ± 12.47	56.42 ± 10.19	1.318	0.192
PT (s)		16.12 ± 3.09	17.83 ± 2.83	2.427	0.018
Cys C (mg/L)		1.68 ± 0.36	2.43 ± 0.47	7.813	0.000
INR		1.57 ± 0.32	1.84 ± 0.39	3.278	0.002
Child-Pugh score (points)		10.09 ± 1.45	12.87 ± 1.29	8.494	0.000
MELD score (points)		11.58 ± 2.34	17.46 ± 2.98	9.547	0.000

MELD: Model for end-stage liver disease; Cys C: Cystatin C; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; TBil: Total bilirubin; PT: Prothrombin time; PLT: Blood platelet count; BUN: Blood urea nitrogen; Alb: Albumin; Scr: Serum creatinine; INR: International normalized ratio.